SMMT - Summit Therapeutics PLC - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SMMT is currently covered by 10 analysts with an average price target of $28.9. This is a potential upside of $13.43 (86.81%) from yesterday's end of day stock price of $15.47.

Summit Therapeutics PLC's activity chart (see below) currently has 95 price targets and 104 ratings on display. The stock rating distribution of SMMT is 25.93% SELL, 51.85% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.78% with an average time for these price targets to be met of 366 days.

Highest price target for SMMT is $43, Lowest price target is $13, average price target is $28.9.

Most recent stock forecast was given by ETZER DAROUT from BARCLAYS on 01-Oct-2026. First documented stock forecast 12-Jun-2015.

Currently out of the existing stock ratings of SMMT, 7 are a SELL (25.93%), 14 are a BUY (51.85%), 6 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 01-Oct-2026

$20

$4.53 (29.28%)

$18

26 days ago
(01-Oct-2026)

4/5 (80%)

$3.31 (19.83%)

180

Buy Since 08-Oct-2025

$43

$27.53 (177.96%)

$40

28 days ago
(29-Sep-2026)

7/10 (70%)

$26.61 (162.36%)

38

Hold Since 23-Jul-2026

1 months 4 days ago
(23-Sep-2026)

4/26 (15.38%)

$6.02 (35.45%)

15

Sell Since 11-Jun-2025

$13

$-2.47 (-15.97%)

2 months 15 days ago
(12-Aug-2026)

1/2 (50%)

$-2.1 (-13.91%)

5

Buy Since 04-Sep-2025

$38

$22.53 (145.64%)

$40

3 months 3 days ago
(24-Jul-2026)

3/8 (37.5%)

$24.34 (178.18%)

56

Show more analysts

Please expand the browser size to see the chart

What is SMMT (Summit Therapeutics PLC) average time for price targets to be met?

On average it took 366 days for the stock forecasts to be reached, with an average price target met ratio of 51.78%.

Which analyst most recently updated their price target on SMMT (Summit Therapeutics PLC)?

Etzer Darout

Which analyst has the most public recommendations on SMMT (Summit Therapeutics PLC)?

Etzer Darout works at BARCLAYS and has 3 price targets and 1 ratings on SMMT

Which analyst is the currently most bullish on SMMT (Summit Therapeutics PLC)?

Yigal Nochomovitz with the highest potential upside of $27.53

Which analyst is the currently most reserved on SMMT (Summit Therapeutics PLC)?

Debjit Chattopadhyay with the lowest potential downside of -$11.47
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?